Bottom line
PRHSX vs HCPIX: the short answer
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and HCPIX (Health Care Ultrasector Profund) share a meaningful slice of their top holdings — about 65% by weight.
But PRHSX is far broader, holding 279 positions to 69 for HCPIX, so beyond the top names it adds exposure HCPIX doesn't have.
PRHSX is cheaper at 0.83% vs 1.76% — a difference of $93 a year per $10,000 invested.
Over five years, HCPIX returned +6.4% a year vs +4.2% for PRHSX (reporting dates differ).
Updated Nov 19, 2026
PRHSX vs HCPIX side by side
| PRHSX | HCPIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | T. Rowe Price | ProShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.83% | 1.76% |
| Annual cost per $10k | $83 | $176 |
| 10-yr cost on $10k (prospectus) | $1,025 | $2,073 |
| Max front load | — | — |
| 12b-1 fee | — | 0% |
| 1-yr return | +17.7% | −1.4% |
| 5-yr return (annualized) | +4.2% | +6.4% |
| 10-yr return (annualized) | +9.1% | +9.2% |
| Best quarter | +23.5% | +22.0% |
| Worst quarter | −15.8% | −21.0% |
| Net assets (fund) | $11.9B | $12.1M |
| Number of holdings | 279 | 69 |
| Portfolio turnover | 62% | 99% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PRHSX | HCPIX | Difference |
|---|---|---|---|
| 2024 | +1.8% | −1.4% | +3.2% |
| 2023 | +3.1% | −1.3% | +4.4% |
| 2022 | −12.2% | −10.6% | −1.6% |
| 2021 | +13.3% | +33.9% | −20.7% |
| 2020 | +30.1% | +16.9% | +13.3% |
| 2019 | +29.1% | +28.4% | +0.7% |
| 2018 | +1.2% | +5.0% | −3.7% |
| 2017 | +28.0% | +32.2% | −4.2% |
| 2016 | −10.4% | −6.5% | −3.8% |
Source: Fund prospectus bar charts
Holdings overlap
16 of PRHSX's top 25 holdings also appear in HCPIX's top 25.
| Holding | PRHSX | HCPIX |
|---|---|---|
| Eli Lilly & Co | 14.28% | 11.83% |
| Johnson & Johnson | 6.63% | 8.03% |
| Unitedhealth Group Inc | 5.99% | 4.90% |
| Abbvie Inc | 5.10% | 5.77% |
| Merck & Co. Inc. | 4.01% | 4.19% |
| Gilead Sciences Inc | 2.82% | 2.10% |
| Thermo Fisher Scientific Inc | 2.52% | 2.78% |
| Vertex Pharmaceuticals Inc | 2.28% | 1.57% |
| Bristol-myers Squibb Co | 2.11% | 1.74% |
| Abbott Laboratories | 1.89% | 2.40% |
| Intuitive Surgical Inc | 1.87% | 1.63% |
| Amgen Inc | 1.82% | 2.71% |
| Stryker Corp | 1.78% | 1.46% |
| Elevance Health Inc | 1.53% | 1.06% |
| Danaher Corp | 1.43% | 1.60% |
Source: SEC Form N-PORT
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
HCPIX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
FAQ
What is the difference between PRHSX and HCPIX?
Which is cheaper, PRHSX or HCPIX?
Should I own both PRHSX and HCPIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.